International Psoriasis Council

Advancing Knowledge. Improving Care.

Kilian

Eyerich

,

MD, PhD

Director and Chair for Department of Dermatology and Venerology
University of Freiburg
Freiburg
,
Germany
Councilor Since: January 1, 2022
IPC Councilor
Professor Kilian Eyerich studied medicine at the University of Würzburg and at TUM. After graduation, he joined TUM’s Medical Life Science and Technology PhD program. He also worked as a postdoctoral researcher at the Istituto Dermopatico Dell’immacolata in Rome. Professor Eyerich has received numerous grants and awards for his translational research activities. These have been from organizations such as the Bavarian Academy of Sciences and Humanities, the German Research Foundation, the Fritz Thyssen Foundation, and the Bavarian Research Foundation. In 2013, he was awarded a Heisenberg Professorship by the German Research Foundation. The research area of Professor Eyerich (b. 1979) is the immunology of inflammatory skin diseases such as psoriasis or atopic eczema. As an MD/PhD, his ultimate goal is to improve patient care through the development of innovative diagnostic and therapeutic tools.
Last Updated:
01/18/2022

Areas of Interest

Dermato-Immunology, studying the interaction of (adaptive) immune cells and epithelial cells; re-classification of inflammatory skin diseases based on molecular events that mediate clinically meaningful outcomes.

Languages Spoken

English, German, Norwegian, Swedish

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026